# Frazier Lifesciences Acquisition Corporation (FLAC)

Source: https://www.quantisnow.com/company/FLAC
Generated: 2026-11-10T09:59:58.205Z

- Ticker: FLAC
- Exchange: NASDAQ
- Sector: Finance
- Industry: Business Services
- IPO year: 2021
- Website: frazierlifesciencesacquisition.com

## About

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

## Latest FLAC news and filings

- 2023-02-15 15:14 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-frazier-lifesciences-acquisition-corporation-4069819)
- 2022-12-02 21:30 UTC [SEC Form 15-12G filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-frazier-lifesciences-acquisition-corporation-3762973)
- 2022-12-01 21:51 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-frazier-lifesciences-acquisition-corporation-3758466)
- 2022-11-25 18:43 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-frazier-lifesciences-acquisition-corporation-3731734)
- 2022-11-25 18:35 UTC [SEC Form 4] [SEC Form 4 filed by Viking Global Investors Lp](https://www.quantisnow.com/insight/sec-form-4-filed-by-viking-global-investors-lp-3731702)
- 2022-11-23 21:36 UTC [SEC Form 8-K] [Frazier Lifesciences Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/frazier-lifesciences-acquisition-corporation-filed-sec-form-8-k-entry-into-3728366)
- 2022-11-23 21:31 UTC [SEC Form 4] [SEC Form 4 filed by Topper David Joseph](https://www.quantisnow.com/insight/sec-form-4-filed-by-topper-david-joseph-3728310)
- 2022-11-23 21:27 UTC [SEC Form 4] [SEC Form 4 filed by Bigham Michael](https://www.quantisnow.com/insight/sec-form-4-filed-by-bigham-michael-3728267)
- 2022-11-23 21:25 UTC [SEC Form 4] [SEC Form 4 filed by Polu Krishna R](https://www.quantisnow.com/insight/sec-form-4-filed-by-polu-krishna-r-3728260)
- 2022-11-23 21:25 UTC [SEC Form 4] [SEC Form 4 filed by Baltera Robert Jr.](https://www.quantisnow.com/insight/sec-form-4-filed-by-baltera-robert-jr-3728252)
- 2022-11-23 21:23 UTC [SEC Form 4] [SEC Form 4 filed by Gallagher Carol Giltner](https://www.quantisnow.com/insight/sec-form-4-filed-by-gallagher-carol-giltner-3728234)
- 2022-11-23 21:11 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-frazier-lifesciences-acquisition-corporation-3728054)
- 2022-11-22 21:17 UTC [SEC Form 25-NSE filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-frazier-lifesciences-acquisition-corporation-3722406)
- 2022-11-22 21:16 UTC [SEC Form 25-NSE filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-frazier-lifesciences-acquisition-corporation-3722386)
- 2022-11-22 21:15 UTC [SEC Form 25-NSE filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-frazier-lifesciences-acquisition-corporation-3722369)
- 2022-11-15 17:56 UTC [SEC Form 8-K] [Frazier Lifesciences Acquisition Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/frazier-lifesciences-acquisition-corporation-filed-sec-form-8-k-submission-of-3690262)
- 2022-11-15 16:12 UTC [Market Chatter] [Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination With NewAmsterdam Pharma Holding B.V.](https://www.quantisnow.com/insight/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-3689613)
- 2022-11-14 23:12 UTC [SEC Form 3] [SEC Form 3: New insider Flynn James E claimed ownership of 2,480,199 units of Class A Ordinary Shares](https://www.quantisnow.com/insight/sec-form-3-new-insider-flynn-james-e-claimed-ownership-3685126)
- 2022-11-14 21:44 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-frazier-lifesciences-acquisition-corporation-3683586)
- 2022-11-09 21:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-frazier-lifesciences-acquisition-corporation-3658397)
- 2022-11-07 11:48 UTC [Market Insight] [$8.5 Million Bet On This Financial Services Stock? 4 Stocks Insiders Are Buying](https://www.quantisnow.com/insight/85-million-bet-on-this-financial-services-stock-4-stocks-3638271)
- 2022-11-04 22:17 UTC [SEC Form 4] [SEC Form 4: Viking Global Investors Lp bought $8,538,385 worth of shares (847,062 units at $10.08)](https://www.quantisnow.com/insight/sec-form-4-viking-global-investors-lp-bought-8538385-worth-3636840)
- 2022-11-04 21:57 UTC [SEC Form 3] [SEC Form 3: New insider Viking Global Investors Lp claimed ownership of 2,824,400 shares](https://www.quantisnow.com/insight/sec-form-3-new-insider-viking-global-investors-lp-claimed-3636788)
- 2022-11-03 21:13 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-frazier-lifesciences-acquisition-corporation-3630196)
- 2022-11-02 12:22 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-frazier-lifesciences-acquisition-corporation-3615476)
- 2022-10-18 20:43 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-frazier-lifesciences-acquisition-corporation-3546732)
- 2022-09-26 12:00 UTC [Leadership Update] [Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors](https://www.quantisnow.com/insight/phathom-pharmaceuticals-appoints-dr-james-topper-to-its-board-of-3450928)
- 2022-09-20 10:06 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-frazier-lifesciences-acquisition-corporation-3429313)
- 2022-08-11 21:27 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-frazier-lifesciences-acquisition-corporation-3275016)
- 2022-08-01 20:01 UTC [SEC Form 425] [SEC Form 425 filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-frazier-lifesciences-acquisition-corporation-3215973)
- 2022-07-28 20:07 UTC [SEC Form 425] [SEC Form 425 filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-frazier-lifesciences-acquisition-corporation-3202498)
- 2022-07-27 21:30 UTC [SEC Form 425] [SEC Form 425 filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-frazier-lifesciences-acquisition-corporation-3195638)
- 2022-07-25 12:35 UTC [Market Insight] [Frazier Lifesciences Acquisition Corporation Shares Resumed Trade At 8:30](https://www.quantisnow.com/insight/frazier-lifesciences-acquisition-corporation-shares-resumed-trade-at-830-3178593)
- 2022-07-25 12:20 UTC [SEC Form 8-K] [Frazier Lifesciences Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/frazier-lifesciences-acquisition-corporation-filed-sec-form-8-k-entry-into-3178468)
- 2022-07-25 12:04 UTC [Market Insight] [NewAmsterdam Pharma Holding B.V. And Frazier Lifesciences Acquisition Corporation Announce Merger Agreement; Says Closing would Bring NewAmsterdam's Pro Forma Cash Balance To At Least $470M In Addition to Total Enterprise Value Of $326M](https://www.quantisnow.com/insight/newamsterdam-pharma-holding-bv-and-frazier-lifesciences-acquisition-corporation-announce-3178361)
- 2022-05-11 23:29 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-frazier-lifesciences-acquisition-corporation-2872891)
- 2022-03-25 21:17 UTC [SEC Form 10-K] [SEC Form 10-K filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-frazier-lifesciences-acquisition-corporation-2628975)
- 2022-02-14 21:45 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Frazier Lifesciences Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-frazier-lifesciences-acquisition-corporation-2414231)
- 2022-02-14 21:11 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-frazier-lifesciences-acquisition-corporation-2413002)
- 2022-02-14 11:19 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-frazier-lifesciences-acquisition-corporation-2404391)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FLAC
- Earnings history: https://www.quantisnow.com/earnings/FLAC
- Dividend history: https://www.quantisnow.com/dividends/FLAC
- Insider transactions: https://www.quantisnow.com/insiders/FLAC
- Options chain: https://www.quantisnow.com/options/FLAC
- SEC 8-K filings only: https://www.quantisnow.com/company/FLAC/8-k
- RSS and alerts for FLAC: https://www.quantisnow.com/docs/rss-feeds.md